MYC and neuroblastoma: Finally, inhibition of CDK7, a transcriptional cyclin-dependent kinase which functions downstream of MYC and is MYC’s 10th-ranked correlation, causes marked regression of aggressive, MYC-driven neuroblastomas in mice (Chipumuro et al, 2014).